REQUEST A DEMO
Total
USD $0.00
Search more companies

Interventional Medical Products S.A. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Interventional Medical Products S.A. Profile Updated: May 22, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Interventional Medical Products S.A. is an enterprise in Colombia, with the main office in Medellin. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on August 18, 2006. The total number of employees is currently 46 (2025). The latest financial highlights indicate a net sales revenue increase of 20.07% in 2024. Its’ total assets recorded a growth of 30.06%. The net profit margin of Interventional Medical Products S.A. increased by 0.57% in 2024.

Headquarters
Calle 10 Sur 51 A 55 Local 505
Medellin; Antioquia;

Contact Details: Purchase the Interventional Medical Products S.A. report to view the information.

Website: http://interventional.com.co

Basic Information
Total Employees:
Purchase the Interventional Medical Products S.A. report to view the information.
Registered Capital:
Purchase the Interventional Medical Products S.A. report to view the information.
Financial Auditors:
Purchase the Interventional Medical Products S.A. report to view the information.
Incorporation Date:
August 18, 2006
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Interventional Medical Products S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
20.07%
Total operating revenue
16.03%
Operating profit (EBIT)
72.76%
EBITDA
71.11%
Net Profit (Loss) for the Period
39.87%
Total Assets
30.06%
Total Equity
78.17%
Operating Profit Margin (ROS)
3.17%
Net Profit Margin
0.57%
Return on Equity (ROE)
-3.93%
Debt/Equity
-14.89%
Quick Ratio
0.05%
Cash Ratio
-0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?